Page 69 - ARNM-2-4

Advances in Radiotherapy
& Nuclear Medicine Different approaches for the computation of BED

equivalent uniform biologically effective dose (EUBED) doi: 10.1080/09553008514550461
Phys Med Biol. 2000;45(1):159-170.
32. Kuperman VY, Spradlin GS. Use of radiation protraction to
doi: 10.1088/0031-9155/45/1/311 escalate biologically effective dose to the treatment target.
Med Phys. 2011;38(12):6553-6560.
20. Niemierko A. Reporting and analyzing dose distributions:
A concept of equivalent uniform dose. Med Phys. doi: 10.1118/1.3656053
1997;24(1):103-110. 33. Brenner DJ, Hall EJ. Conditions for the equivalence of
doi: 10.1118/1.598063 continuous to pulsed low dose rate brachytherapy. Int J
Radiat Oncol Biol Phys. 1991;20(1):181-190.
21. Lee SP, Leti MY, Smathers JB, McBride WH, Parker RG,
Withers HR. Biologically effective dose distribution based doi: 10.1016/0360-3016(91)90158-Z
on the linear quadratic model and its clinical relevance. Int J 34. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in
Radiat Oncol Biol Phys. 1995;33(2):375-389. prolonged fraction delivery. Int J Radiat Oncol Biol Phys.
doi: 10.1016/0360-3016(95)00162-R 2004;59(1):242-249.
22. Wheldon TE, Deehan C, Wheldon EG, Barretta A. doi: 10.1016/j.ijrobp.2004.01.004
The linear-quadratic transformation of dose-volume 35. Benedict SH, Yenice KM, Followill D, et al. Stereotactic body
histograms in fractionated radiotherapy. Radiother Oncol. radiation therapy: The report of AAPM Task Group 101.
1998;46(3):285-295. Med Phys. 2010;37(8):4078-4101.
doi: 10.1016/S0167-8140(97)00162-X doi: 10.1118/1.3438081
23. O’Donoghue JA. Implications of nonuniform tumor doses 36. Porter EH. The statistics of dose/cure relationships for
for radioimmunotherapy. J Nucl Med. 1999;40(8):1337-1341. irradiated tumours. Part I. Br J Radiol. 1980;53(627):210-227.
24. Singh G, Oinam AS, Kamal R, Handa B, Kumar V, Rai B. doi: 10.1259/0007-1285-53-627-210
Voxel based BED and EQD2 evaluation of the radiotherapy
treatment plan. J Med Phys. 2018;43(3):155-161. 37. Deasy J. Poisson formulas for tumor control probability with
clonogen proliferation Radiat Res. 1996;145(3):382-384.
doi: 10.4103/jmp.JMP_29_18
doi: 10.2307/3578994
25. Varian Medical Systems. Velocity V. 4.1, Instructions for Use.
Polo Alto, CA, USA: Varian Medical Systems; 2023. 38. Webb S, Evanst PM, Swindell W, Deasy JO. A proof that
uniform dose gives the greatest TCP for fixed integral
26. RaySearch Laboratories. Biological Models Reference dose in the planning target volume. Phys Med Biol.
Information, Raystation Reference Manual. Stockholm, 1994;39(11):2091-2098.
Sweden: RaySearch Laboratories; 2024.
doi: 10.1088/0031-9155/39/11/018
27. Dale R. The application of the linear-quadratic dose-effect
equation to fractionated and protracted radiotherapy. Br J 39. Drzymala RE, Mohan R, Brewster L, Chu J, Goitein M,
Radiol. 1985;58(690):515-528. Harms W, Urie M. Dose-volume histograms. Int J Radiat
Oncol Biol Phys. 1991;21(1):71-78.
doi: 10.1259/0007-1285-58-690-515
doi: 10.1016/0360-3016(91)90168-4
28. Fowler JF. The linear-quadratic formula and progress in
fractionated radiotherapy. Br J. Radiol. 1989;62(740):679-694. 40. Kuperman VY, Lubich LM. Impact of target dose
inhomogeneity on BED and EUD in lung SBRT. Phys Med
doi: 10.1259/0007-1285-62-740-679 Biol. 2021;66(1):01NT02.
29. McMahon SJ. The linear quadratic model: Usage, doi: 10.1088/1361-6560/abd0d1
interpretation and challenges. Phys Med Biol.
2018;64(1):01TR01. 41. Shuryak I, Carlson DJ, Brown MJ, Brenner DJ. High-dose
and fractionation effects in stereotactic radiation therapy:
doi: 10.1088/1361-6560/aaf26a Analysis of tumor control data from 2965 patients. Radiother
30. Hawkins RB. Effect of heterogeneous radio sensitivity on Oncol. 2015;115(3):327-334.
the survival, alpha beta ratio and biologic effective dose doi: 10.1016/j.radonc.2015.05.013
calculation of irradiated mammalian cell populations. Clin 42. Onishi H, Araki T, Shirato H, et al. Stereotactic
Transl Radiat Oncol. 2017;4:32-38.
hypofractionated high-dose irradiation for stage I
doi: 10.1016/j.ctro.2017.03.001 nonsmall cell lung carcinoma: Clinical outcomes in 245
subjects in a Japanese multiinstitutional study. Cancer.
31. Thames HD. An ‘Incomplete-repair’ model for survival after
fractionated and continuous irradiations. Int J Radiat Biol 2004;101(7):1623-1631.
Relat Stud Phys Chem Med. 1985;47(3):319-39. doi: 10.1002/cncr.20539

Volume 2 Issue 4 (2024) 9 doi: 10.36922/arnm.4826